A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, paving the way for safer, targeted cancer therapies.
Viruses in different life cycles can promote elemental cycling (e.g., carbon, nitrogen, and phosphorus) by viral lysing or auxiliary metabolic genes (AMGs) metabolisms. Viruses can increase microbial ...